Mens turbataA history of the troubled mind

Treatment · 1917–1950s

Malaria therapy

From 1917 doctors deliberately infected people with general paralysis with malaria, hoping the fever would halt the disease. It won a Nobel Prize in 1927 and was used until penicillin replaced it.

Bust of Julius Wagner-Jauregg at the University of Vienna.
Bust of Julius Wagner-Jauregg at the University of Vienna. Herbert Josl. Wikimedia Commons, CC BY-SA 3.0.

The idea behind malaria therapy was old: physicians since antiquity had noticed that a bout of fever sometimes seemed to lift a madness. What was new in 1917 was the decision to give patients a dangerous disease on purpose, and the reason it was tried was that the illness it targeted was worse.

General paralysis of the insane filled a large share of asylum beds in the early twentieth century and killed nearly everyone who had it, usually within a few years. In Britain, close to one in five men who died in asylums died of it4. In 1913 Hideyo Noguchi and J. W. Moore found the syphilis organism in the brains of patients, confirming it as a late stage of syphilis2. The arsenic drug salvarsan, the first effective treatment for syphilis, and the older mercury had both failed against general paralysis3.

Fever as a remedy

Julius Wagner-Jauregg, professor of psychiatry in Vienna, had been interested in fever since 1883, when he saw a woman recover from a psychosis after a feverish skin infection. In 1887 he published on the effect of fevers on psychoses, and around 1900 he tried tuberculin to induce fever in patients with general paralysis, with results he thought encouraging3.

In 1917 a colleague, Alfred Fuchs, told him of a soldier in the clinic with tertian malaria, a type that could be cut short with quinine. Wagner-Jauregg injected the soldier's blood into nine patients with general paralysis. After seven to twelve days of fever they were given quinine and an arsenical drug. Of the nine, one died, two were sent on to asylums, and six improved; four of those six later relapsed, and two recovered fully enough to return to work3. By late 1921 he had treated more than 200 patients, of whom he said 50 had recovered enough to work3.

Spread, and a Nobel Prize

The method spread quickly. In Britain it began at Whittingham Mental Hospital in Lancashire in July 1922, at first with infected blood carried between hospitals4,1. By 1925, according to the Board of Control, it was in use at 43 institutions, which treated 444 patients that year1. In the same year a malaria laboratory was set up at Horton Hospital, Epsom, under Colonel Sydney Price James, which kept mosquitoes infected with known strains and sent them to hospitals across the country4.

In 1927 Wagner-Jauregg received the Nobel Prize in Physiology or Medicine, the first psychiatrist to do so3,5. Scientific papers on malaria therapy rose from a handful a year to about 160 in 19293. For the next fifteen years it was the standard treatment for general paralysis in Europe and North America.

What it achieved

The Board of Control was cautious but hopeful. It recorded that of the 444 patients treated in 1925, 61 had been discharged, 31 of them as recovered, and it took seriously the objection that general paralysis had always shown natural remissions:

They contend that insufficient attention has been given to the frequency and duration of these remissions. It is obvious that, in ultimately assessing the value of induced malaria as a means of treatment, full weight must be given to this contention1

Quotation checked against the 1926 text

The Board still judged that malaria offered "at present the best chance" to patients1. Later series reported "good remission" in roughly a quarter to a third of those treated. In 1931 a London County Council report on 579 cases found about 30 per cent with good remissions; many of those discharged were still working at follow-up4. The cost was heavy. Deaths during or soon after treatment ranged from 14 to 27 per cent across six centres compared by the Horton superintendent W. D. Nicol, and James himself conceded that the treatment had "a tendency to lethality"4.

Patients as subjects

The patients were detained in asylums, often already severely ill, and many could not have consented in any modern sense. At Whittingham the superintendent wrote that consent "was always asked of relatives" at first but that he later thought this unnecessary, since malaria had become the usual treatment4. Wagner-Jauregg's own first trials have been called "ethically ambiguous" by Cynthia Tsay; the Swedish psychiatrist Bror Gadelius reportedly opposed his Nobel Prize, calling the infection of a paralysed patient with malaria a crime3. In Britain the Board of Control regarded the treatment as experimental, and patients at Horton were also used to study malaria itself and to test new antimalarial drugs, work that advanced malariology but with an uncertain ethical basis4.

Penicillin

In 1943 John Mahoney reported that penicillin cured syphilis. As penicillin became available after the war, new cases of general paralysis fell sharply and malaria therapy faded with them3,4. The Horton laboratory continued as a malaria reference centre until 19734. Wagner-Jauregg's reputation has also been revisited for reasons beyond the treatment: late in life he supported eugenics and, after 1938, applied to join the Nazi Party3.

Key dates

  1. 1887 Julius Wagner-Jauregg publishes on the effect of feverish illnesses on psychoses.
  2. 1917 In Vienna, Wagner-Jauregg injects nine patients with general paralysis with blood from a soldier with malaria.
  3. July 1922 Malaria therapy begins in Britain at Whittingham Mental Hospital, Lancashire.
  4. 1925 A malaria laboratory opens at Horton Hospital, Epsom, and becomes Britain's main supplier of infected mosquitoes for treatment.
  5. 1927 Wagner-Jauregg receives the Nobel Prize in Physiology or Medicine for malaria therapy.
  6. 1943 John Mahoney reports that penicillin cures syphilis, beginning the end of malaria therapy.

See the full timeline

Sources

  1. Primary source Board of Control (England and Wales), Twelfth Annual Report of the Board of Control for the year 1925, London: HMSO (1926). Quotations checked against this text.
  2. Primary source Hideyo Noguchi, J. W. Moore, A demonstration of Treponema pallidum in the brain in cases of general paralysis, Journal of Experimental Medicine 17(2) (1913).
  3. Scholarship Cynthia J. Tsay, Julius Wagner-Jauregg and the Legacy of Malarial Therapy for the Treatment of General Paresis of the Insane, Yale Journal of Biology and Medicine 86(2) (2013).
  4. Scholarship Graham Ash, Gordon D. L. Bates, Mosquitoes, Medical Officers and Mental Asylums: Malariotherapy in the UK and the Rise of the Horton Laboratory, Topics in the History of Medicine 5 (British Society for the History of Medicine) (2025).
  5. Wikipedia Malaria therapy, Wikipedia.

Cross-checked with Wikidata Q387152 and the English Wikipedia article.

Pages that mention Malaria therapy